Lymphocyte volume and conductivity indices of the haematology analyser Coulter® GEN.STM in lymphoproliferative disorders and viral diseases

被引:29
作者
Silva, M
Fourcade, C
Fartoukh, C
Lenormand, B
Buchonnet, G
Callat, MP
Leclerc, C
Basuyau, JP
Vasse, M
机构
[1] CHU Rouen, Hop Charles Nicolle, Hematol Lab, Rouen, France
[2] Ctr Hosp Victor Dupouy, Lab, Argenteuil, France
[3] CHU, Hop Charles Nicolle, Serv Malad Infect & Trop, Rouen, France
[4] Etab Francais Sang, Bois Guillaume, France
[5] Ctr Henri Becquerel, F-76038 Rouen, France
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2006年 / 28卷 / 01期
关键词
lymphocyte volume; lymphocyte conductivity; GEN; lymphoproliferative diseases; viral disease;
D O I
10.1111/j.1365-2257.2006.00748.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The haematology analyser Coulter (R) GEN.S (TM) gives a set of data-'positional parameters'-defining white blood cell (WBC) populations by mean of index values (mean and standard deviation of volume, conductivity and scatter, used to identify the WBC populations). The volume and conductivity parameters related to the lymphocytes were analysed at diagnosis in patients suffering from chronic B-lymphocytic leukaemia (B-CLL), other non-CLL lymphoproliferative disorders (OLPD) and viral diseases. The standard deviation of volume index (SDVI) is significantly higher in the three groups, whereas the mean volume index (MVI) is significantly lower in B-CLL, and increased in OLPD and viral diseases. These two groups could be distinguished by their mean conductivity index (MCI), which is significantly lower in viral disease group. Cut-offs were calculated for each parameter by the mean of Receiver Operating Characteristic (ROC) analysis. The study of the detection performances showed that the combination of lymphocyte count with SDVI, MVI and MCI could be used with a good sensitivity and specificity to discriminate between the most frequent lymphocyte pathologies, even in patients with normal lymphocyte count.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 10 条
[1]  
Amouroux I, 2003, ANN BIOL CLIN-PARIS, V61, P576
[2]  
Arroyo JL, 2000, HAEMATOLOGICA S3, V85, P49
[3]  
Grimaldi E., 1998, LAB HEMATOLOGY, V4, P264
[4]  
Kessler C., 1997, LAB HEMATOL, V3, P32
[5]  
Lima M, 2000, BLOOD, V96, P3858
[6]  
MATUTES E, 1994, LEUKEMIA, V8, P1640
[7]  
Matutes E, 2000, Rev Clin Exp Hematol, V4, P22, DOI 10.1046/j.1468-0734.2000.00002.x
[8]  
Oriol A, 2003, HEMATOLOGICA S7, V88, P41
[9]   Preliminary evaluation of the new hematology analyzer COULTER® GEN•STM in a university hospital [J].
Picard, F ;
Gicquel, C ;
Marnet, L ;
Guesnu, M ;
Levy, JP .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (06) :681-686
[10]  
Swets John., 1982, EVALUATION DIAGNOSTI